Terms: = Pancreatic cancer AND BCL7A, BCL7, 605, ENSG00000110987 AND Staging
3 results:
1. Prognostic factors and survival after surgical resection of pancreatic neuroendocrine tumor with validation of established and modified staging systems.
Benetatos N; Hodson J; Marudanayagam R; Sutcliffe RP; Isaac JR; Ayuk J; Shah T; Roberts KJ
Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):169-175. PubMed ID: 29576279
[TBL] [Abstract] [Full Text] [Related]
2. High Expression of Cell Division Cycle 42 Promotes pancreatic cancer Growth and Predicts Poor Outcome of pancreatic cancer Patients.
Yang D; Zhang Y; Cheng Y; Hong L; Wang C; Wei Z; Cai Q; Yan R
Dig Dis Sci; 2017 Apr; 62(4):958-967. PubMed ID: 28181096
[TBL] [Abstract] [Full Text] [Related]
3. A retrospective cohort study of pancreatic neuroendocrine tumors at single institution over 15 years: New proposal for low- and high-grade groups, validation of a nomogram for prognosis, and novel follow-up strategy for liver metastases.
Ye L; Ye H; Zhou Q; Li Z; Lin Q; Tan L; Gao W; Fu Z; Zheng S; Chen R
Int J Surg; 2016 May; 29():108-17. PubMed ID: 27000717
[TBL] [Abstract] [Full Text] [Related]
